Ying Lü
Impact in
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 14
- Circular RNAs in diseases 8
- Oncology 31
- Cancer Cells and Metastasis 11
- Co-authors
- Kinam Park (6 shared papers)Anders Bennick (2 shared papers)Jun Mao (14 shared papers)Yanqiang Zhong (25 shared papers)Jie Gao (15 shared papers)C.H. Arrowsmith (4 shared papers)Bo Song (11 shared papers)Hao Zou (17 shared papers)
- Journals
- International Journal of Pharmaceutics (8 papers)Journal of the American College of Cardiology (7 papers)Journal of Controlled Release (7 papers)Nanomedicine (6 papers)Chemico-Biological Interactions (6 papers)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Ying Lü
245 papers receiving 7.6k citations
Peers
Comparison fields: 5 of 165
- Pharmaceutical Science 637
- Biomaterials 1.2k
- Cancer Research 1.1k
- Molecular Biology 3.7k
- Biological Psychiatry 101
Countries citing papers authored by Ying Lü
This map shows the geographic impact of Ying Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Lü more than expected).
Fields of papers citing papers by Ying Lü
This network shows the impact of papers produced by Ying Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Lü. The network helps show where Ying Lü may publish in the future.
Co-authors
The 25 scholars most cited alongside Ying Lü, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 254 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 436 | |
| 2 | 2005 | 230 | |
| 3 | 1998 | 201 | |
| 4 | 2013 | 175 | |
| 5 | 2018 | 145 | |
| 6 | 2004 | 137 | |
| 7 | 2016 | 135 | |
| 8 | 2017 | 134 | |
| 9 | 1997 | 120 | |
| 10 | 2011 | 118 | |
| 11 | 2019 | 112 | |
| 12 | 1998 | 112 | |
| 13 | 2014 | 105 | |
| 14 | 2017 | 98 | |
| 15 | 2018 | 97 | |
| 16 | 2013 | 88 | |
| 17 | 1997 | 86 | |
| 18 | 2018 | 84 | |
| 19 | 2005 | 83 | |
| 20 | 2002 | 83 |
About Ying Lü
Ying Lü is a scholar working on Molecular Biology, Oncology, Immunology, Cancer Research and Biomaterials, having authored 254 papers that have together received 7.8k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (24 papers), MicroRNA in disease regulation (17 papers), Advanced Drug Delivery Systems (14 papers), Nanoplatforms for cancer theranostics (14 papers), RNA Interference and Gene Delivery (14 papers), Cancer Cells and Metastasis (11 papers), Circular RNAs in diseases (8 papers) and Autophagy in Disease and Therapy (8 papers). The work is most often cited by research in Pharmaceutical Science (637 citations), Biomaterials (1.2k citations), Cancer Research (1.1k citations), Molecular Biology (3.7k citations) and Biological Psychiatry (101 citations). Ying Lü has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Kinam Park, Anders Bennick, Jun Mao, Yanqiang Zhong, Jie Gao, C.H. Arrowsmith, Bo Song, Hao Zou, Tao Qin and Zhiguo Sun. Their work appears in journals such as International Journal of Pharmaceutics, Journal of the American College of Cardiology, Journal of Controlled Release, Nanomedicine and Chemico-Biological Interactions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.